Karsten Schrör

Simvastatin reduces platelet thromboxane formation and restores normal platelet sensitivity against prostacyclin in type IIa hypercholesterolemia.

Karsten Schrör, P Löbel, Elisabeth Steinhagen‐Thiessen · PubMed · 1989 · 60 citations

Hypertension, Normal Platelet Sensitivity, Type Iia Hypercholesterolemia +18

Thromboxane‐dependent platelet activation <i>in vivo</i> precedes arterial thrombosis in thrombocythaemia: a rationale for the use of low‐dose aspirin as an antithrombotic agent

Perry J.J. van Genderen, Fransisco J Prins, Jan Michiels et al. · British Journal of Haematology · 1999 · 58 citations · Full text

Hypertension, Low‐dose Aspirin, Platelet Pathobiology +20

Tolerance development to antimitogenic actions of prostacyclin but not of prostaglandin E1 in coronary artery smooth muscle cells

Tom-Philipp Zucker, Detlef Bönisch, Andreas Hasse et al. · European Journal of Pharmacology · 1998 · 56 citations

Antimitogenic Actions, Cardiovascular Disease, Atherosclerosis +11

Regulation of hyaluronan synthesis by vasodilatory prostaglandins

Karsten Schrör, Jens W. Fischer · Thrombosis and Haemostasis · 2007 · 32 citations

Glycobiology, Immunology, Cellular Physiology +21

Stimulation of coronary vascular PGI2 by organic nitrates

Karsten Schrör, B. Ahland, Peter H. Weiss et al. · European Heart Journal · 1988 · 15 citations